Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitation of Helicobacter pylori in the stomach using quantitative polymerase chain reaction assays.

Helicobacter·2000
Same author

Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer.

The American journal of pathology·2000
Same author

Helicobacter pylori and gastric cancer: both primary and secondary preventive measures are required.

Archives of internal medicine·2000
Same author

Proinflammatory activation of neutrophils and monocytes by Helicobacter pylori is not associated with cagA, vacA or picB genotypes.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2000
Same author

Modified Genta triple stain for identifying Helicobacter pylori.

Journal of clinical pathology·2000
Same author

Furazolidone combination therapies for Helicobacter pylori infection in the United States.

Alimentary pharmacology & therapeutics·2000

Related Experiment Video

Updated: Jul 17, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Aspirin and the stomach.

D Y Graham, J L Smith

    Annals of Internal Medicine
    |March 1, 1986
    PubMed
    Summary

    Aspirin causes gastric damage, with effects often linked to dosage. However, acute injury assessments may not predict long-term risks like chronic ulcers or bleeding.

    Area of Science:

    • Gastroenterology and Pharmacology

    Background:

    • Aspirin frequently induces acute gastric mucosal damage, detectable endoscopically or via gastrointestinal blood loss.
    • Adverse effects of aspirin are generally dose-dependent, impacting both acute injury and chronic ulcer risk.
    • Gastric adaptation can complicate the interpretation of acute aspirin administration studies.

    Purpose of the Study:

    • To analyze the dose-response relationship of aspirin-induced gastric injury.
    • To evaluate the predictive value of acute mucosal damage for chronic complications.
    • To highlight the limitations of current assessment methods for aspirin's gastrointestinal effects.

    Main Methods:

    • Review of endoscopic and microbleeding studies on acute aspirin administration.
    • Analysis of dose-response effects in relation to gastric adaptation.

    More Related Videos

    Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
    08:56

    Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

    Published on: November 30, 2022

    Gastric Point of Care Ultrasound in Adults: Image Acquisition and Interpretation
    05:50

    Gastric Point of Care Ultrasound in Adults: Image Acquisition and Interpretation

    Published on: September 22, 2023

    Related Experiment Videos

    Last Updated: Jul 17, 2026

    Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
    13:38

    Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

    Published on: January 18, 2017

    Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
    08:56

    Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

    Published on: November 30, 2022

    Gastric Point of Care Ultrasound in Adults: Image Acquisition and Interpretation
    05:50

    Gastric Point of Care Ultrasound in Adults: Image Acquisition and Interpretation

    Published on: September 22, 2023

  • Correlation of acute mucosal injury findings with chronic gastric ulcer and bleeding risks.

    • Main Results:

    • Aspirin's adverse effects, including acute gastric damage and bleeding, show a clear dose-response relationship.
    • Gastric adaptation can diminish injury with continued aspirin treatment, complicating acute study interpretations.
    • Acute endoscopic findings of mucosal injury do not reliably predict the occurrence or severity of chronic gastric ulcers or gastrointestinal bleeding.

    Conclusions:

    • The dose of aspirin is a critical factor in acute gastric mucosal injury.
    • Acute endoscopic assessments of aspirin-induced damage have limited value in predicting chronic gastrointestinal risks.
    • Symptom absence does not correlate with mucosal damage, rendering it an unreliable indicator.